ARTICLE | Company News
Laboratorios Farmaceuticos Rovi, Novavax deal
February 15, 2010 8:00 AM UTC
Novavax terminated its 2009 deal to license its recombinant virus-like particle (VLP) vaccine technology to Laboratorios Farmaceuticos to develop seasonal and pandemic influenza vaccines for the Spani...